期刊文献+

佳木斯地区健康人群与高血压患者CYP3A4* 1G基因多态性分析 被引量:9

The polymorphisms analysis of healthy people and hypertension patients with CYP3A4* 1G gene in Jiamusi
下载PDF
导出
摘要 目的:通过比较本地区健康人与高血压患者CYP3A4*1G基因多态性的差异,探讨CYP3A4*1G基因多态性与高血压病的易感关系。方法 :采用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)方法检测本地区健康人与高血压患者的CYP3A4*1G基因型分布及等位基因频率,通过χ2检验来比较本地区健康人与高血压患者基因型分布差异和等位基因频率差异。结果:高血压患者与健康人的基因分布及等位基因频率差异有显著性和高度显著性(P<0.05和P<0.01)。结论:高血压病的发生与CYP3A4*1G的碱基变异具有相关性。 Objective: To explore the relationship between CYP3A4 ~ 1G gene polymorphisms and the Hyper- tension pathogenesis, by comparing the differences of CYP3A4 * 1G Gene polymorphisms in patients with hyperten- sion and healthy populations in Jiamusi. Method: Polymerase chain reaction -restriction fragment length polymor- phism (PCR -RFLP) method was applied to detect the genotype distribution and the allele frequencies of CYP3A4 * 1G in patients with hypertension and healthy people; and to compare the differences between them according to Chi -square criterion. Results: There existed significant differences in the gene distribution and allele frequencies of CYP3A4 * 1G in patients with hypertension and healthy people (P 〈 0.05 ,P 〈 0.01 ). Conclusion:The hyper- tension pathogenesis is related with the base variations of CYP3A4 * 1G.
出处 《黑龙江医药科学》 2015年第1期7-9,共3页 Heilongjiang Medicine and Pharmacy
基金 黑龙江省自然科学基金项目 编号:2011-86 紫禁城国际药师论坛专题科研课题 编号:ZJC-2012-30
关键词 高血压 CYP3A4*1G 基因多态性 PCR-RFLP CYP3A4 * 1G hypertension gene polymorphism PCR - RFLP
  • 相关文献

参考文献8

二级参考文献68

共引文献39

同被引文献56

  • 1罗丹,鄢盛恺,程歆琦,宋耀虹.2型糖尿病合并冠心病患者的同型半胱氨酸水平及代谢关键酶基因多态性特点[J].卫生研究,2009,38(1):39-42. 被引量:10
  • 2杨榆玲,龙莉,瞿秋,吴玲,何永蜀,张彦.血管紧张素Ⅱ1型受体A1166C多态性在云南彝族人群中的分布[J].昆明医科大学学报,2012,33(5):43-46. 被引量:5
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 4谈恒山,张海霞,方芸,葛卫红.近10年国内药物体外代谢研究进展[J].江苏药学与临床研究,2006,14(5):297-300. 被引量:5
  • 5Frosst P,Blom HJ,Milos R,et al.A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics . 1995
  • 6A Second Common Mutation in the Methylenetetrahydrofolate Reductase Gene: An Additional Risk Factor for Neural-Tube Defects?(J)The American Journal of Human Genetics . 1998 (5)
  • 7Frosst P,Blam H J,Milos R,et al.A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate. Nature Genetics . 1995
  • 8N. Di Simone,P. Riccardi,N. Maggiano,A. Piacentani,M. D’Asta,A. Capelli,A. Caru.Effect of folic acid on homocysteine-induced trophoblast apoptosis. Molecular Human Reproduction . 2004
  • 9Gemmati Donato,Ongaro Alessia,Tognazzo Silvia,Catozzi Linda,Federici Federica,Mauro Endri,Della Porta Matteo,Campioni Diana,Bardi Antonella,Gilli Giuseppe,Pellati Agnese,Caruso Angelo,Scapoli Gian L,De Mattei Monica.Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin’s lymphoma patients: association with toxicity and survival. Haematologica . 2007
  • 10G. Callejn,A. Mayor-Olea,A.J. Jimnez,M.J. Gaitn,A.R. Palomares,F. Martnez,M. Ruiz,Armando Reyes-Engel.Genotypes of the C677T and A1298C polymorphisms of the MTHFR gene as a cause of human spontaneous embryo loss. Human Reproduction . 2007

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部